References
- Livermore DM. Permeation of β-lactam antibiotics into Escherichia coli, Pseudomonas aeruginosa, and other Gram-negative bacteria. Rev Infect Dis 1988; 10: 691–698.
- Godfrey AJ, Bryan LE. Penetration of β-lactam through Pseudomonas aeruginosa porin channels. Antimicrob Agents Chemother 1987; 31: 1216–1221.
- Kobayashi Y, Takahashi I, Nakae T. Diffusion of β-lactam antibiotics through liposome membranes containing purified porins. Antimicrob Agents Chemother 1982; 22: 775–780.
- Nikaido H, Rosenberg EY, Foulds J. Porin channels in Escherichia coli: studies with β-lactam intact cells. J Bacteriol. 1983; 153: 232–240.
- Mitsuyama J, Hiruma R, Yamaguchi A, Sawai T. Identification of porins in outer membrane of Proteus, Morganella, and Providencia spp. and their role in outer membrane permeation of β-lactam. Antimicrob Agents Chemother 1987; 31: 379–384.
- Yoshimura F, Nikaido H. Diffusion of β-lactam antibiotics through the porin channels of Escherichia coli K-12. Antimicrob Agents Chemother 1985; 27: 84–92.
- Hancock REW, Wong PGW. Compounds which increase the permeability of the Pseudomonas aeruginosa outer membrane. Antimicrob Agents Chemother 1984; 26: 48–52.
- Foulds J, Murray DM, Chai T, Rosner JL. Decreased permeation of cephalosporins through the outer membrane of Escherichia coli grown in salicylates. Antimicrob Agents Chemother 1989, 33: 412–417.
- Rosner JL. Nonheritable resistance to chloramphenicol and other antibiotics induced by salicylates and other chemotactic repellents in Escherichia coli K-12. Proc Natl Acad Sci USA 1985; 82: 8771–8774.
- Sawai T, Hiruma R, Kawana N, Kaneko M, Taniyasu F, Inami A. Outer membrane permeation of β-lactam antibiotics in Escherichia coli, Proteus mirabilis, and Enterobacter cloacae. Antimicrob Agents Chemother 1982; 22: 585–592.
- O’Callahan CH, Morris A, Kirby SM, Shingler AH. Novel method for detection of β-lactamase by using a chromogenic cephalosporin substrate. Antimicrob Agents Chemother 1972; 1: 283–288.
- National Committee for Clinical Laboratory Standards. Methods for dilution susceptibility tests for bacteria that grow aerobically. Villanova. Pa: National Committee for Laboratory Standards 1983.
- Needs CJ, Brooks PM. Clinical pharmacokinetics of the salicylates. Clin Pharmacokinet 1985; 10: 164–177.
- Petersen AK, Fitzgerald GA. Dose-related kinetics of aspirin. N Engl J Med 1984; 311: 1206–1211.
- Daikos GL, Lolans VT, Jackson GG. Alterations in outer membrane proteins of Pseudomonas aeruginosa associated with selective resistance to quinolones. Antimicrob Agents Chemother 1988; 32: 785–787.
- Hirai K, Aoyama H, Irikura T, Iyobe S, Mitsuhashi S. Differences in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coli. Antimicrob Agents Chemother 1986; 29: 535–538.
- Chapman JS, Georgopapadakow NH. Routes of quinolone permeation in Escherichia coli. Antimicrob Agents Chemother 1988; 32: 438–442.